Castillo, Jennie Ruelas 
; Neupane, Pranita ; Karanika, Styliani ; Krug, Stefanie ; Quijada, Darla ; Garcia, Andrew; Ayeh, Samuel; Yilma, Addis; Sher, Alan ; Fotouhi, Nader; Serbina, Natalya; Karakousis, Petros C. ; Costa, Diego Luís
Fonte: Antimicrobial Agents and Chemotherapy. Unidade: ICB
Assuntos: IMUNOLOGIA, TUBERCULOSE, MYCOBACTERIUM TUBERCULOSIS, INFECÇÕES BACTERIANAS GRAM-POSITIVAS, RESISTÊNCIA MICROBIANA ÀS DROGAS, QUIMIOTERAPIA, ADJUVANTES IMUNOLÓGICOS, INIBIDORES DE ENZIMAS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTILLO, Jennie Ruelas et al. The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model. Antimicrobial Agents and Chemotherapy, v. 68, n. 2, p. 34 , 2023Tradução . . Disponível em: https://doi.org/10.1101/2023.08.09.552716. Acesso em: 01 dez. 2025.APA
Castillo, J. R., Neupane, P., Karanika, S., Krug, S., Quijada, D., Garcia, A., et al. (2023). The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model. Antimicrobial Agents and Chemotherapy, 68( 2), 34 . doi:10.1101/2023.08.09.552716NLM
Castillo JR, Neupane P, Karanika S, Krug S, Quijada D, Garcia A, Ayeh S, Yilma A, Sher A, Fotouhi N, Serbina N, Karakousis PC, Costa DL. The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model [Internet]. Antimicrobial Agents and Chemotherapy. 2023 ; 68( 2): 34 .[citado 2025 dez. 01 ] Available from: https://doi.org/10.1101/2023.08.09.552716Vancouver
Castillo JR, Neupane P, Karanika S, Krug S, Quijada D, Garcia A, Ayeh S, Yilma A, Sher A, Fotouhi N, Serbina N, Karakousis PC, Costa DL. The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model [Internet]. Antimicrobial Agents and Chemotherapy. 2023 ; 68( 2): 34 .[citado 2025 dez. 01 ] Available from: https://doi.org/10.1101/2023.08.09.552716
